Final Programme - iuphar

FC04 Pharmacoepidemiology, current controversies and
opportunities
Leaders: Bert Leufkens, (The Netherlands) & Jesper Hallas, (Denmark)
FC04.4 In utero exposure to drugs
Chairs: Lolkje TW de Jong-van den Berg, (The Netherlands) &
Corinne de Vries, (The Netherlands)
14:30 - 14:55 FC04.4.1 The impact of thalidomide and its revival as a vital medicine.
Lessons learned from history
Trent D Stephens, (USA)
14:55 - 15:20 FC04.4.2 Pharmacological considerations of drug teratogenicity – why animal studies are not
sufficient
Per Damkier, (Denmark)
15:20 - 15:45 FC04.4.3 Unique methodological features in the pharmacoepidemiology of birth defects
Corinne de Vries, (UK)
15:45 - 16:15 COFFEE BREAK
16:15 - 16:40 FC04.4.4 Determining drug effects – clinical considerations when establishing birth outcomes
Lolkje TW de Jong-van den Berg, (UK)
16:40 - 16:55 FC04.4.5 Free Communication Presentation:
Risk of ischemic stroke associated with antidepressant drug use in elderly persons
Gianluca Trifiro, (Italy), J Dieleman, A Caputi, G Gambassi, M Sturkenboom
16:55 - 17:10 FC04.4.6 Free Communication Presentation:
Drug safety signal detection and substantiation by integrative mining of electronic healthcare
records and biomedical knowledge: preliminary results from the EU-ADR project
Gianluca Trifiro, (Italy), M Sturkenboom, C Diaz Acedo, A Fourrie Reglat, F Sanz,
JL Oliveira, E Molero, J van der Lei, on behalf of the EU-ADR Consortium
84 Tuesday 20 July ■ 14:30 - 17:15 ■ Auditorium 11